InMode Ends Sale Talks: No Good Offers Found
InMode has stopped its review of buyout or merger proposals after deciding none were good enough for shareholders.
InMode has stopped its review of buyout or merger proposals after deciding none were good enough for shareholders.
Steel Partners proposes to buy 51% of InMode shares at $18 each, a 29% premium, citing poor stock performance and excessive cash holdings.
InMode, the Israeli medical aesthetics technology company, is in advanced talks for a $1.1 billion acquisition by a foreign investment fund, representing a 25% premium.